• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • ITM, DCB sign agreement for Targeted Radionuclide Therapy biospectrumasia
    September 03, 2019
    The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITM’s proprietary brand Solucin® for Targeted Radionuclide Therapy (TRT).
  • Medtronic introduces IN.PACT Admiral DCB in Japan biospectrumasia
    August 20, 2018
    IN.PACT Admiral DCB is a clinically proven, primary endovascular therapy that treats femoropopliteal disease, reduces interventions, and preserves future treatment options.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service